Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Shield Thera (STX) Share Price

Price 5.65p on 30-10-2026 at 19:35:09
Change 0.15p 2.73%
Buy 5.80p
Sell 5.50p
Last Trade: Sell 100,000.00 at 5.555p
Day's Volume: 1,048,744
Last Close: 5.65p
Open: 5.50p
ISIN: GB00BYV81293
Day's Range 5.42p - 5.65p
52wk Range: 3.70p - 12.35p
Market Capitalisation: £60.69m
VWAP: 5.498772p
Shares in Issue: 1.07b

Shield Thera (STX) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 100,000 5.555p Ordinary
16:08:39 - 30-Oct-26
Sell* 12,116 5.533p Ordinary
15:41:36 - 30-Oct-26
Buy* 89,343 5.574p Ordinary
15:33:38 - 30-Oct-26
Buy* 17,913 5.56p Ordinary
15:30:01 - 30-Oct-26
Buy* 271,539 5.52p Ordinary
15:02:55 - 30-Oct-26
Buy* 103,350 5.502p Ordinary
15:02:03 - 30-Oct-26
Buy* 282 5.60p Ordinary
13:54:14 - 30-Oct-26
Sell* 33,057 5.45p Ordinary
11:22:02 - 30-Oct-26
Sell* 509 5.45p Ordinary
11:02:39 - 30-Oct-26
Sell* 150,000 5.42p Uncrossing Trade
11:00:22 - 30-Oct-26
See more Shield Thera trades

Shield Thera (STX) Share Price History

Time period:
to
Date Open High Low Close Volume
30th Oct 2026 (Fri) 5.50 5.65 5.42 5.65 1,048,744
29th Oct 2026 (Thu) 5.45 5.50 5.42 5.50 393,608
28th Oct 2026 (Wed) 5.45 5.45 5.45 5.45 48,462
27th Oct 2026 (Tue) 5.50 5.50 5.35 5.45 545,020
26th Oct 2026 (Mon) 5.50 5.50 5.50 5.50 715,712
23rd Oct 2026 (Fri) 5.60 5.60 5.50 5.50 1,062,272
22nd Oct 2026 (Thu) 5.70 5.70 5.60 5.60 1,216,631
21st Oct 2026 (Wed) 5.55 5.70 5.55 5.70 822,163
20th Oct 2026 (Tue) 5.35 5.55 5.35 5.55 2,993,754
19th Oct 2026 (Mon) 5.20 5.35 5.20 5.35 1,585,167
16th Oct 2026 (Fri) 5.20 5.20 5.20 5.20 590,859
15th Oct 2026 (Thu) 5.25 5.20 5.20 5.20 710,554
14th Oct 2026 (Wed) 5.25 5.25 5.25 5.25 213,809
13th Oct 2026 (Tue) 5.25 5.25 5.25 5.25 666,006
12th Oct 2026 (Mon) 5.30 5.30 5.25 5.25 745,052
9th Oct 2026 (Fri) 5.25 5.30 5.25 5.30 581,506
8th Oct 2026 (Thu) 5.45 5.45 4.95 5.25 3,562,695
7th Oct 2026 (Wed) 5.55 5.50 5.50 5.50 1,341,652
6th Oct 2026 (Tue) 5.95 5.60 5.60 5.60 2,166,795
5th Oct 2026 (Mon) 5.95 5.95 5.95 5.95 542,287
2nd Oct 2026 (Fri) 6.05 6.05 5.95 5.95 1,289,836
1st Oct 2026 (Thu) 5.90 6.05 5.90 6.05 2,175,616
See more Shield Thera price history

Shield Thera (STX) Regulatory News

Date Source Headline
30th Oct 2026 12:30 pm RNS Total Voting Rights
30th Sep 2026 7:00 am RNS Total Voting Rights
1st Sep 2026 7:00 am RNS Total Voting Rights
27th Aug 2026 4:00 pm RNS Shield assumes full control of ACCRUFeR® in the US
20th Aug 2026 7:00 am RNS Interim results for the six months ended 30 Jun 26
3rd Aug 2026 12:02 pm RNS Total Voting Rights
30th Jul 2026 7:00 am RNS Q2 and H1 2026 Trading Update
28th Jul 2026 7:00 am RNS ACCRUFeR® Phase 3 pediatric trial published
30th Jun 2026 7:52 am RNS Block Listing 6 Monthly Return
18th Jun 2026 4:20 pm RNS Results of 2026 Annual General Meeting
See more Shield Thera regulatory news

Shield Thera (STX) Share News

TRADING UPDATES: Arkle finds uranium; hVIVO poaches CFO from Futura

12th Oct 2026 14:40

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

WINNERS & LOSERS: STV hurt by Studios "slowdown"; Trifast falls

8th Sep 2026 11:20

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Tuesday. Read More

WINNERS & LOSERS: McBride rises on deal win; Watkin Jones slumps

28th Aug 2026 10:13

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Friday. Read More

Shield Therapeutics takes full control of ferric maltol product in US

27th Aug 2026 17:00

(Alliance News) - Shield Therapeutics PLC shares spiked on Thursday afternoon after the pharmaceutical company announced it will assume full commercial responsibility for its ferric maltol supplement in the US. Read More

Shield Therapeutics loss shrinks as milestone, royalty receipts grow

20th Aug 2026 11:05

(Alliance News) - Shield Therapeutics PLC on Thursday said it remains on track for operating profitability in 2026 after reporting higher half-year sales, despite some challenges in the US. Read More

See more Shield Thera news
FTSE 100 Latest
Value10,729.78
Change7.71

Login to your account

Forgot Password?

Not Registered